NCT00151476View on ClinicalTrials.gov

Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients

TerminatedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Familial Adenomatous Polyposis (FAP)
Interventions
DRUG

Celecoxib

800 mg total daily dosing

OTHER

Routine Medical Care

Trial Locations (4)

44195

Pfizer Investigational Site, Cleveland

M5G1X5

Pfizer Investigational Site, Toronto

DK-2650

Pfizer Investigational Site, Hvidovre

08036

Pfizer Investigational Site, Barcelona

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00151476 - Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients | Biotech Hunter | Biotech Hunter